KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Equity Ratio: 2010-2024

Historic Equity Ratio for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to 0.35.

  • Emergent BioSolutions' Equity Ratio rose 15.89% to 0.40 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.40, marking a year-over-year increase of 15.89%. This contributed to the annual value of 0.35 for FY2024, which is 2.45% down from last year.
  • Per Emergent BioSolutions' latest filing, its Equity Ratio stood at 0.35 for FY2024, which was down 2.45% from 0.36 recorded in FY2023.
  • Emergent BioSolutions' 5-year Equity Ratio high stood at 0.54 for FY2021, and its period low was 0.35 during FY2024.
  • For the 3-year period, Emergent BioSolutions' Equity Ratio averaged around 0.38, with its median value being 0.36 (2023).
  • As far as peak fluctuations go, Emergent BioSolutions' Equity Ratio increased by 8.27% in 2021, and later decreased by 19.56% in 2022.
  • Emergent BioSolutions' Equity Ratio (Yearly) stood at 0.50 in 2020, then rose by 8.27% to 0.54 in 2021, then declined by 19.56% to 0.44 in 2022, then fell by 18.74% to 0.36 in 2023, then dropped by 2.45% to 0.35 in 2024.